Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve To consider and approve inter alia the audited financial results of the Company for the quarter and financial year ended March 31st, 2025

pdf

Brawn Biotech Ltd.

30 Apr 2025

19.00

-0.89%

Corp. Note

Brawn Biotech Ltd - 530207 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyBrawn Biotech Ltd 2CIN NO.L74899DL1985PLC022468 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Priyanka Sharma Designation: Company Secretary and Compliance Officer EmailId: solution@brawnbiotech.com Name of the Chief Financial Officer: Pooja Pandey Designation: Chief Financial Officer EmailId: collections@brawnlabs.in Date: 30/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Brawn Biotech Ltd.

14 Apr 2025, 05:41PM

19.00

-0.89%

Company Update

Brawn Biotech Ltd - 530207 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for quarter ended 31st March 2025.

pdf

Is Brawn Biotech Ltd. worth buying?

10 Votes:

Buy 100.0%